Somatic ELF4 truncation mutation linked to autoinflammatory disease in pediatric patient

A case report details a pediatric patient presenting with autoinflammatory disease, recurrent mucocutaneous inflammation, and periodic fever. The study investigated a somatic truncating mutation in the ELF4 gene as a potential driver of these symptoms. Immune cells from the patient were compared against wild-type immune cells derived from the same individual to assess functional differences.

Transcriptional analysis identified mutation-associated alterations across multiple immune cell types. Specifically, natural killer (NK) cells demonstrated reduced antiviral and interferon-related signaling. Conversely, CD16 monocytes exhibited enhanced inflammatory pathways related to Th17 differentiation and inflammatory bowel disease.

No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in this case report. The study expands the known disease spectrum of ELF4 deficiency by identifying somatic truncation as a genetic mechanism underlying autoinflammatory diseases. However, the single-patient design and lack of a control group preclude definitive causal inference or generalization to other populations.

The primary relevance for practice is recognizing ELF4 somatic truncation as a potential etiology in patients with unexplained autoinflammatory presentations. Clinicians should consider this genetic mechanism when evaluating pediatric cases with recurrent fever and mucocutaneous inflammation, particularly if standard etiologies are excluded. Further research with larger cohorts is required to validate these findings and establish treatment implications.